Pay in 4 interest-free payments of $8.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
KI-20227 inhibits disease progression in a collagen-induced arthritis mouse model
A phase I trial and in vitro studies combining ABT-751 with carboplatin in previously treated non-small cell lung cancer patients
5-bis((Z)-4-fluoro-3-nitrobenzylidene)azepan-4-one
JK184 was suggested to use at 1-5 µM concentration in vitro and in the cellular assays
SAR407899 (1-3 mg/kg
LM11A-31 HCl - CAS# 1243259-19-9 size:2mg solid KI-20227 inhibits disease progression inLM11A 31 HCl, CAS No. 1243259 19 9, is a small molecule p75NTR modulator and proNGF antagonist, in preventing diabetes induced BRB breakdown. Targeting p75NTR signalling using LM11A 31, an orally bioavailable receptor modulator, may offer an effective, safe and non invasive therapeutic strategy for treating macular oedema, a major cause of blindness in diabetes. Product information CAS Number: 1243259 19 9 Molecular Weight: 316. 27 Formula:
US$ 129.00
US$ 110.00
US$ 13.50
US$ 129.00
US$ 12.00
US$ 129.00
US$ 129.00
US$ 129.00
US$ 129.00
US$ 129.00
US$ 120.00
US$ 129.00
US$ 129.00
US$ 129.00
US$ 135.00
US$ 139.00
US$ 139.00